If you need a company to pay you while you wait for it to grow, Evion Group is not that company. The stock has never declared a dividend, and the July general meeting the company is calling is not about distributing cash to shareholders - it's about approving dilution to fund another speculative acquisition.
The competitor headlines frame this as a move toward streamlined online shareholder access. That's technically true. But what the meeting is really deciding is whether existing shareholders accept further share issuance so the company can buy a fluorspar project in Nevada. The online access is just the plumbing. The substance is dilution.
Here is what you need to understand before you decide whether this belongs in your portfolio at all.
What Evion does - and doesn't - produce right now
Evion is a vertically integrated graphite developer with projects being developed in Madagascar, India, and Europe. The flagship Maniry graphite project in Madagascar has successfully fast tracked... to the completed Bankable Feasibility Study (BFS) Stage and carries EU strategic project status. That means it has regulatory momentum, not revenue. The Maniry mine is not producing.
The one operation generating cash is a small joint venture in India called Panthera Graphite. It began shipping expandable graphite since March 2025 at prices above US$3,000 a tonne. For FY2026, that operation is projected to deliver US$530k in EBITDA. EBITDA is earnings before interest, taxes, depreciation, and amortization - a rough proxy for operating cash generation. Half a million dollars on a project this early is a proof-of-concept, not a cash-flow engine. It's a credible demonstration that the expandable graphite business model is commercially viable, but it is not a dividend source.
What the capital raise actually does
In May, Evion announced raising A$6.6m to secure a Nevada fluorspar option at A$0.03 per share to fund the acquisition of the Carp fluorspar project in Nevada. That was then upsized its two-tranche share placement to raise about A$7.24 million at A$0.03 per share. Tranche 1 settled in mid-May. Tranche 2 is subject to an extraordinary general meeting of the Company's shareholders expected to be held in early July 2026.
The math is straightforward. At A$0.03 per share, Tranche 2 adds roughly 24 million new shares. With 577,749,600 shares outstanding, existing shareholders face roughly 4% dilution if the resolution passes. At the current trading price near A$0.05, the company's market cap sits around A$29 million - making that dilution materially meaningful relative to the company's size, even if the percentage looks modest in isolation.
What the company gets for your dilution
Fluorspar is a critical mineral used in hydrogen production, steel manufacturing, and increasingly in battery supply chains. The Nevada acquisition broadens Evion from a graphite play into a small critical-minerals platform. Management sees value in diversification beyond a single commodity and a single geography.
That makes sense as a corporate strategy. It does not change the fact that you are now buying an option on a fluorspar project's future development alongside a graphite project that isn't producing yet. Both assets need capital, time, and execution to generate cash. Neither is paying anyone today.
The bear case, stated plainly
This is a junior miner running out of runway and asking shareholders to fund the next step. The company has no capital and contractual expenditure commitments in place as of June 2025 according to its annual report, but development spend burns through reserves. The India JV is a promising pilot, not a scalable operation yet. Maniry needs funding partners to move from studies to construction. The fluorspar project adds another funding requirement to the table. Each step forward demands more capital, which means more dilution, which means existing shareholders own a smaller slice of a still-speculative asset base.
If graphite prices fall, if the EU funding partners don't materialize, or if fluorspar development proves more expensive than modeled, the dilution cycle continues without a payout to cushion the hit.
What this means for income investors
I'll say it directly: Evion Group has no dividend, no dividend history, and no visible path to a dividend in the next few years. The July meeting is not about income distribution. It's about whether you want to be diluted so the company can add another speculative asset to its development pipeline.
If you are here because someone mentioned graphite's role in batteries and you assumed there might be income to collect, there isn't any. This is pure development-stage optionality. The graphite thesis may be real - demand for battery materials is structural, and the India JV proves the product sells - but "real thesis" and "paying you to wait" are not the same thing.
For investors building a portfolio that funds life through cash flow, Evion does not belong in the income allocation. If you have a speculative sleeve for unproven miners and you're comfortable with dilution as the cost of optionality, that's a separate conversation. But don't confuse the two.
The July vote is coming. If it passes, the A$7.24 million raises, the dilution locks in, and the fluorspar acquisition moves forward. If you're investing for income, you don't need to vote on it - you just need to understand what it is before you put money to work.
We are here, first as human beings who need to be paid while we figure the rest out. A graphite developer asking shareholders to fund its next option is a growth story, not an income one. Know the difference before you allocate.